Suchergebnisse - "Yu-Pei Chen"

PubPharm (24)

1

Patterns and prognosis of regional recurrence in nasopharyngeal carcinoma after intensity‐modulated radiotherapy

in: Cancer Medicine | 2023

von Xiao‐Tang Xiao | Yi‐Shan Wu | Yu‐Pei Chen | +5

2

Characterization of tea (Camellia sinensis L.) flower extract and insights into its antifungal susceptibilities of Aspergillus flavus

in: BMC Complementary Medicine and Therapies | 2023

von Fangfang Chen | Yu-Pei Chen | Hongtan Wu | +4

3

Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets

enthalten in: Pharmaceutics | 2022

von Yu, P. | Huang, C. | Kuo, C. | +9

4

Selection and validation of chemotherapy beneficiaries among elderly nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiation therapy (IMRT): a large real-world study

in: Radiation Oncology | 2022

von Yan-Ling Wu | Kai-Bin Yang | Ying Huang | +10

5

Agricultural management practices influence the soil enzyme activity and bacterial community structure in tea plantations

in: Botanical Studies | 2021

von Yu-Pei Chen | Chia-Fang Tsai | P. D. Rekha | +5

6

Chemotherapeutic and targeted agents can modulate the tumor microenvironment and increase the efficacy of immune checkpoint blockades

in: Molecular Cancer | 2021

von Jun-Yan Li | Yu-Pei Chen | Ying-Qin Li | +2

7

Spatial heterogeneity of immune infiltration predicts the prognosis of nasopharyngeal carcinoma patients

in: OncoImmunology | 2021

von Ya-Qin Wang | Xu Liu | Cheng Xu | +12

8

Identification of cross-talk between m6A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types

in: Journal of Hematology & Oncology | 2020

von Yu-Tong Chen | Jia-Yi Shen | Dong-Ping Chen | +7

9

Correction: Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study

in: Journal for ImmunoTherapy of Cancer | 2020

von Yu-Pei Chen | Ya-Qin Wang | Yan-Ping Mao | +10

10

Correction: Dual oxidase 1 limits the IFNγ-associated antitumor effect of macrophages

in: Journal for ImmunoTherapy of Cancer | 2020

von Yu-Pei Chen | Ya-Qin Wang | Yan-Ping Mao | +10